"I remember Don stating a few times that we'll be surprized how fast cancer trials move."

Hahahahahhaha,,,,Toinv tell me you are making a funny!!,,,,,"Don said".....lmfao.....what is not to understand that this man has absolutely no idea about research or trial timelines and or costing,,,please say you have noticed,,,, :o) ,,,,a non-professional heading up a complex biotech company should be enuff to make any investor shudder....and his inability has been obvious,,,as is the teams!,,,,cuz we know DMcC has no input to trial design or other technical requirement in respect to epigenetics,,,,,and is definitly at arms length from inner workings in the other company,,and it shows......well,,,,,just think about it,,,its tuff enuff for an experienced PhD in the position of CEO of a penny biotech company, even with good science, to move iteslf onto the world investing stage....best hope is that ZEN gets sold off in some fashion,,and DMcC steps down or moves aside asap before we implode,,.,preferably is shuffled out to pasture...its way past time!!,,,,jmo